Copy and paste this code to insert a reference to this article in your
blog or online community profile:
 
 
Will Display Like this:
 
Promising Pre-clinical Validation of Targeted Radionuclide Therapy Using a [131I] Labelled Iodoquinoxaline Derivative for an Effective Melanoma Treatment
JCST/Vol.1.1 001-007 (2009) . 1:1, (2009)
https://doi.org/10.4172/1948-5956.1000001